Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis

AIM: To conduct a systematic review and meta‐analysis to understand the timing and factors associated with anti‐programmed cell death protein‐1 (PD‐1)/anti‐programmed cell death protein‐1 ligand (PD‐L1) inhibitor‐induced Type 1 diabetes. METHODS: We searched MEDLINE, EMBASE, SCOPUS and Cochrane data...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabet Med
Autors principals: Akturk, H. K., Kahramangil, D., Sarwal, A., Hoffecker, L., Murad, M. H., Michels, A. W.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Systematic Review or Meta‐analysis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698212/
https://ncbi.nlm.nih.gov/pubmed/31199005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.14050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars